Cyclo Therapeutics, Inc.
USD0.03
+0.00 (+0.00%)
CEO
N. Scott Fine
IPO Date
2020-12-18
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.03
Prev. Close
$0.03
Day Low
$0.03
Day High
$0.03
52W Low
$0.03
52W High
$0.61
Market Cap
$0.00B
Volume
0.03M
| -0.8 |
| 31 Dec 2021 | FY | 90.2% | -902.1% | -91.3% | -73.3% | 0.01 | 5.07 | -1.7 |
| 31 Dec 2020 | FY | 92.7% | -987.7% | -85.4% | -62.9% | 0.02 | 3.83 | -0.8 |
| 31 Dec 2019 | FY | 92.5% | -761.9% | -819.9% | -186.6% | 0.06 | 1.26 | -4.8 |
| 31 Dec 2018 | FY | 89.6% | -420.7% | -428.7% | -145.8% | 0.00 | 1.44 | -15.4 |
| 31 Dec 2017 | FY | 89.3% | -309.7% | -334.6% | -183.5% | 0.00 | 2.01 | -6.6 |
| 31 Dec 2016 | FY | 86.8% | -281.0% | -276.8% | -226.0% | 0.00 | 4.77 | -6.4 |
| 31 Dec 2015 | FY | 86.9% | -268.4% | -68.1% | -53.6% | 0.20 | 2.49 | -12.1 |
| 31 Dec 2014 | FY | 82.6% | -37.8% | -13.6% | -11.2% | 0.18 | 3.33 | -54.6 |
| -1.4 |
| 31 Mar 2024 | Q1 | -313.2% | -2145.3% | -712.0% | -60.6% | 1.09 | 1.01 | -2.2 |
| 31 Dec 2023 | Q4 | -181.5% | -1812.0% | -118.6% | -42.6% | 0.22 | 1.45 | -1.8 |
| 30 Sept 2023 | Q3 | 92.2% | -963.0% | 453.3% | -85.2% | -0.04 | 0.83 | -1.2 |
| 30 Jun 2023 | Q2 | 83.0% | -3958.8% | 312.3% | -99.9% | -0.03 | 0.75 | -1.2 |
| 31 Mar 2023 | Q1 | 93.3% | -3285.2% | 1140.9% | -122.2% | -0.12 | 0.89 | -0.5 |
| 31 Dec 2022 | Q4 | 91.6% | -2575.5% | -655.0% | -114.1% | 0.00 | 1.19 | -0.6 |
| 30 Sept 2022 | Q3 | 92.7% | -938.9% | -75.6% | -50.0% | 0.00 | 2.93 | -1.0 |
| 30 Jun 2022 | Q2 | 86.4% | -636.3% | -35.4% | -29.1% | 0.00 | 5.60 | -1.2 |